Shared on 25 Aug 25
Fair value Decreased 12%GoHealth’s price target has been revised downward to $18.40, primarily reflecting reduced expectations for both future earnings multiples and revenue growth. What's in the News GoHealth has formed a Transformation Committee with new board members to evaluate strategic opportunities, including acquisitions, securitizations, and capital structure options.
Shared on 10 Aug 25
Fair value Decreased 9.26%Despite higher revenue growth forecasts, GoHealth’s future P/E multiple has dropped sharply, indicating reduced investor confidence in earnings quality or sustainability, leading to a lower consensus price target of $19.60. What's in the News GoHealth has formed a Transformation Committee to evaluate acquisitions, financial structure options, securitizations, and other strategic opportunities for value creation.
Shared on 24 Apr 25
Fair value Increased 158%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 158%AnalystConsensusTarget has increased revenue growth from 4.5% to 6.8%, decreased discount rate from 11.4% to 9.0% and decreased shares outstanding growth rate from 0.1% to 0.0%.